Verrica Pharmaceuticals/ US92511W1080 /
16/05/2024 21:59:50 | Chg. +0.08 | Volume | Bid- | Demandez à- | Haut | Bas |
---|---|---|---|---|---|---|
9.14USD | +0.88% | 3,216 Chiffrre d'affaires: 30,485.83 |
-Bid taille: - | -Ask la taille: - | 9.62 | 9.14 |
GlobeNewswire
04:26
RF Acquisition Corp II Announces Pricing of $100 Million Initial Public Offering
GlobeNewswire
04:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sha...
GlobeNewswire
04:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lin...
GlobeNewswire
04:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Mal...
GlobeNewswire
04:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Qui...
GlobeNewswire
04:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Hir...
GlobeNewswire
02:01
Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds The Chemours Company Shareholders of ...
GlobeNewswire
02:00
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Sonder Holdings Inc. Investors to Secure Counsel Before ...
GlobeNewswire
02:00
HUTCHMED Highlights Sovleplenib Phase III ESLIM-01 Study and Hematological Malignancy Programs Data ...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page